临床研究

子宫内膜癌患者血清泛素耦联酶2C、三基序蛋白27表达水平及其与病理参数的相关性

  • 柴菲 ,
  • 陈振文 ,
  • 刘宏艳 ,
  • 李肃 ,
  • 龚媛媛 ,
  • 赵莹莹
展开
  • 1.山西医科大学汾阳学院病理教研室(山西汾阳 032200);山西省汾阳医院
    2.山西省汾阳医院 病理科032200 )
    3.山西省汾阳医院 妇产科(山西汾阳032200 )

收稿日期: 2023-08-15

  网络出版日期: 2024-07-09

基金资助

山西省卫生健康委员会项目(2020TD12)

Expression level of serum UBE2C and TRIM27 in patients with endometrial cancer and their correlation with pathological parameters

  • Fei CHAI ,
  • Zhenwen CHEN ,
  • Hongyan LIU ,
  • Su LI ,
  • Yuanyuan GONG ,
  • Yingying. ZHAO
Expand
  • 1.Teaching and Research Office of Pathology,Fenyang College,Shanxi Medical University,Fenyang 032200,China
    2.Department of Pathology,Fenyang Hospital,Fenyang 032200,China

Received date: 2023-08-15

  Online published: 2024-07-09

摘要

目的 探究子宫内膜癌(EC)患者血清泛素耦联酶2C(UBE2C)、三基序蛋白27(TRIM27)表达水平及其与病理参数的相关性。 方法 选取医院2020年3月至2023年3月96例EC患者为EC组,同期子宫内膜非典型增生(EAH)患者65例为EAH组,体检健康者80例为对照组。酶联免疫法分析血清UBE2C、TRIM27水平。ROC曲线分析血清UBE2C、TRIM27水平评估EC发生的预测价值。 结果 EC患者血清UBE2C、TRIM27水平显著高于体检健康者(P < 0.05)。EC患者血清UBE2C、TRIM27水平与肿瘤直径、肿瘤分化程度、淋巴结转移、FIGO分期、肌层浸润深、宫颈受累、雌激素受体表达、孕激素受体表达有关(P < 0.05)。血清UBE2C与TRIM27水平呈正相关(r = 0.475,P < 0.001);血清UBE2C、TRIM27水平与肿瘤直径、淋巴结转移、FIGO分期、肌层浸润深度呈正相关,与肿瘤分化程度、雌激素受体表达、孕激素受体表达呈负相关(P < 0.05)。UBE2C、TRIM27联合评估EC发生的AUC显著高于单项检测(ZUBE2C-联合 = 3.406,P < 0.001,ZTRIM27-联合 = 3.285,P = 0.001)。 结论 EC患者血清UBE2C、TRIM27表达水平上调,与病理参数密切相关,血清UBE2C、TRIM27水平可为早期诊断EC提供参考。

本文引用格式

柴菲 , 陈振文 , 刘宏艳 , 李肃 , 龚媛媛 , 赵莹莹 . 子宫内膜癌患者血清泛素耦联酶2C、三基序蛋白27表达水平及其与病理参数的相关性[J]. 实用医学杂志, 2024 , 40(13) : 1808 -1813 . DOI: 10.3969/j.issn.1006-5725.2024.13.008

Abstract

Objective To investigate the expression level of serum ubiquitin-conjugating enzyme 2C (UBE2C) and tripartite motif-containing protein 27 (TRIM27) in patients with endometrial cancer (EC) and their correlation with pathological parameters. Methods A total of 96 EC patients from March 2020 to March 2023 were selected as EC group; 65 patients with endometrial atypical hyperplasia (EAH) as EAH group, and 80 healthy subjects as the control group. Enzyme linked immunosorbent assay was applied to analyze the expression level of serum UBE2C and TRIM27. The relationship between serum UBE2C, TRIM27, and pathological data was analyzed; receiver operating characteristic was applied to evaluate the predictive value of serum UBE2C and TRIM27 level for EC. Results The level of serum UBE2C and TRIM27 of EC patients was obviously higher than that in healthy subjects (P < 0.05), and was correlated with tumor diameter, tumor differentiation, lymph node metastasis, FIGO stage, muscle layer invasion depth, cervical involvement, estrogen receptor expression, and progestogen receptor expression (P < 0.05). There was positive correlation between serum UBE2C and TRIM27 (r = 0.475, P < 0.001); and the level of serum UBE2C and TRIM27 was positively correlated with tumor diameter, lymph node metastasis, FIGO stage, and depth of musclular invasion, but negatively with tumor differentiation, estrogen receptor expression, and progestogen receptor expression (P < 0.05). The combination of UBE2C and TRIM27 had obviously higher AUC in evaluating EC than single detection (ZUBE2C-combination=3.406, P < 0.001, ZTRIM27-combination = 3.285, P = 0.001). Conclusion The expression level of UBE2C and TRIM27 in serum of EC patients is up-regulated, which is closely related to pathological parameters. The level of serum UBE2C and TRIM27 can provide reference for early diagnosis of EC.

参考文献

1 MAKKER V, MACKAY H, RAY-COQUARD I, et al. Endometrial cancer[J]. Nat Rev Dis Primers, 2021, 7(1):1-44. doi:10.1038/s41572-021-00324-8
2 COLL-DE LA RUBIA E, MARTINEZ-GARCIA E, DITTMAR G, et al. Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis[J]. J Clin Med, 2020, 9(6):1-20. doi:10.3390/jcm9061900
3 YUAN L, YANG Z, ZHAO J, et al. Pan-Cancer Bioinformatics Analysis of Gene UBE2C[J]. Front Genet, 2022, 13(1):1-11. doi:10.3389/fgene.2022.893358
4 LIN S, QIU L, LIANG K, et al. KAT2A/E2F1 Promotes Cell Proliferation and Migration via Upregulating the Expression of UBE2C in Pan-Cancer[J]. Genes (Basel), 2022, 13(10):1-21. doi:10.3390/genes13101817
5 LIU S, TIAN Y, ZHENG Y, et al. TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-β-catenin signaling[J]. Aging (Albany NY), 2020, 12(24):25564-25580. doi:10.18632/aging.104163
6 USSAKLI C, USUBUTUN A, DINCER N, et al. Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation)[J]. Pol J Pathol, 2016,67(3):221-227. doi:10.5114/pjp.2016.63773
7 周琦,吴小华,刘继红,等.子宫内膜癌诊断与治疗指南(第四版)[J].中国实用妇科与产科杂志, 2018, 34(8):880-886.
8 中华医学会病理学分会女性生殖疾病学组.子宫内膜癌病理诊断规范[J].中华病理学杂志, 2020, 49(3):214-219. doi:10.3760/cma.j.issn.0529-5807.2020.03.002
9 MARIN-JIMENEZ J A, GARCIA-MULERO S, MATIAS-GUIU X, et al. Facts and Hopes in Immunotherapy of Endometrial Cancer[J]. Clin Cancer Res, 2022, 28(22):4849-4860. doi:10.1158/1078-0432.ccr-21-1564
10 COADA C A, DONDI G, RAVEGNINIi G, et al. Classification Systems of Endometrial Cancer: A Comparative Study about Old and New[J]. Diagnostics (Basel), 2021, 12(1):1-15. doi:10.3390/diagnostics12010033
11 YEN T T, WANG T L, ADER A N, et al. Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer[J]. Int J Gynecol Pathol, 2020, 39(1):26-35. doi:10.1097/pgp.0000000000000585
12 张瑜,张静,王乐,等.血清人附睾蛋白4及糖类抗原125对判断子宫内膜癌淋巴结转移的临床意义[J].实用医学杂志, 2020, 36(10):1340-1348. doi:10.3969/j.issn.1006-5725.2020.10.014
13 NJOKU K, BARR C E, CROSBIE E J. Current and Emerging Prognostic Biomarkers in Endometrial Cancer[J]. Front Oncol, 2022, 12(1):1-16. doi:10.3389/fonc.2022.890908
14 BROOKS R A, FLEMING G F, LASTRA R R, et al. Current recommendations and recent progress in endometrial cancer[J]. CA Cancer J Clin, 2019, 69(4):258-279. doi:10.3322/caac.21561
15 LU Z N, SONG J, SUN T H, et al. UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway[J]. Chin Med J (Engl), 2021, 134(20):2465-2474. doi:10.1097/cm9.0000000000001708
16 LIU Y, ZHAO R, CHI S, et al. UBE2C Is Upregulated by Estrogen and Promotes Epithelial-Mesenchymal Transition via p53 in Endometrial Cancer[J]. Mol Cancer Res, 2020, 18(2):204-215. doi:10.1158/1541-7786.mcr-19-0561
17 DASTSOOZ H, CEREDA M, DONNA D, et al. A Comprehensive Bioinformatics Analysis of UBE2C in Cancers[J]. Int J Mol Sci, 2019, 20(9):1-19. doi:10.3390/ijms20092228
18 ZHANG Y, LI X, GONG Y, et al. Aberrant expression of UBE2C in endometrial cancer and its correlation to epithelial mesenchymal transition[J]. Medicine (Baltimore), 2023, 102(20):1-6. doi:10.1097/md.0000000000033834
19 ZHAO R, LIU Y, WANG Z, et al. UBE2C-mediated Autophagy Inhibition via Ubiquitination of SIRT1 Contributes to Endometrial Cancer Progression[J]. Mol Cancer Res, 2023, 21(6):564-577. doi:10.1158/1541-7786.mcr-22-0825
20 YU C, RAO D, WANG T, et al. Emerging roles of TRIM27 in cancer and other human diseases[J]. Front Cell Dev Biol, 2022, 10(1):1-10. doi:10.3389/fcell.2022.1004429
21 YU H, WAN L, TANG Z, et al. TRIM27 regulates the expression of PDCD4 by the ubiquitin?proteasome pathway in ovarian and endometrial cancer cells[J]. Oncol Rep, 2022, 48(1):1-11. doi:10.3892/or.2022.8331
22 LI Y, MENG Q, WANG L, et al. TRIM27 protects against cardiac ischemia-reperfusion injury by suppression of apoptosis and inflammation via negatively regulating p53[J]. Biochem Biophys Res Commun, 2021, 557(1):127-134. doi:10.1016/j.bbrc.2021.03.061
23 王蒙. 术前IMP3、RFP检测在子宫内膜癌诊断中的应用[J]. 山东医药, 2018, 58(1):84-86. doi:10.3969/j.issn.1002-266X.2018.01.028
文章导航

/